Epithelial ovarian cancer cancers adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Ovary Tumor Cells, Cultured Epithelial Cells Epithelium Neoplastic Stem Cells Cardia Spheroids, Cellular Ascitic Fluid Prostate Esophagogastric Junction

Organisms3

Mice, Nude Cola Mice, SCID

Diseases58

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Adenocarcinoma Cystadenocarcinoma, Serous Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Carcinoma, Endometrioid Carcinoma Lung Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Stomach Neoplasms Peritoneal Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Cystadenocarcinoma, Mucinous Cystadenocarcinoma Endometrial Neoplasms Colonic Neoplasms Adenocarcinoma, Papillary Neoplasms, Cystic, Mucinous, and Serous Breast Neoplasms Ascites Prostatic Neoplasms Disease Progression Esophageal Neoplasms Fallopian Tube Neoplasms Genetic Predisposition to Disease Carcinoma, Pancreatic Ductal Neoplasms Carcinoma, Squamous Cell Cell Transformation, Neoplastic Uterine Cervical Neoplasms Colorectal Neoplasms Barrett Esophagus Carcinoma, Non-Small-Cell Lung Adenocarcinoma, Bronchiolo-Alveolar Cystadenocarcinoma, Papillary Rectal Neoplasms Cystadenoma, Serous Neovascularization, Pathologic Mixed Tumor, Mesodermal Neoplasms, Multiple Primary Precancerous Conditions Urinary Bladder Neoplasms Mammary Neoplasms, Experimental Genital Neoplasms, Female Cystadenoma Disease Models, Animal Carcinoma, Small Cell Gastrointestinal Neoplasms Liver Neoplasms Carcinoma, Papillary Granulosa Cell Tumor Adenoma Neoplastic Syndromes, Hereditary Cystadenoma, Mucinous Pelvic Neoplasms

Chemicals and Drugs60

CA-125 Antigen Tumor Markers, Biological Paclitaxel Cisplatin Antineoplastic Agents Carboplatin Neoplasm Proteins Platinum Epididymal Secretory Proteins Platinum Compounds RNA, Messenger Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents, Phytogenic DNA, Neoplasm BRCA2 Protein Antigens, Neoplasm Tumor Suppressor Protein p53 BRCA1 Protein RNA, Small Interfering Folate Receptor 1 Receptor, erbB-2 RNA, Neoplasm Cancer Vaccines Altretamine Topotecan Talc Receptor, Epidermal Growth Factor Antibodies, Monoclonal Organoplatinum Compounds Contraceptives, Oral Taxoids Deoxycytidine MicroRNAs Mucin-1 Receptors, Estrogen Proto-Oncogene Proteins Transcription Factors GPI-Linked Proteins DNA-Binding Proteins Receptors, Progesterone Fluorouracil Nuclear Proteins Ki-67 Antigen Antigens, CD44 Membrane Proteins Antibodies, Monoclonal, Humanized Mammaglobin B Antibodies, Neoplasm Prostate-Specific Antigen Cyclophosphamide Tumor Suppressor Proteins Antibiotics, Antineoplastic Cadherins Antimetabolites, Antineoplastic Carcinoembryonic Antigen Estrogens Vascular Endothelial Growth Factor A Tamoxifen Bridged Compounds Anticarcinogenic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Neoplasm Staging Prognosis Early Detection of Cancer Survival Analysis Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Survival Rate Disease-Free Survival Reverse Transcriptase Polymerase Chain Reaction Second-Look Surgery Gene Expression Profiling Retrospective Studies Risk Factors Kaplan-Meier Estimate Treatment Outcome Xenograft Model Antitumor Assays Follow-Up Studies Case-Control Studies Tissue Array Analysis Combined Modality Therapy Risk Prospective Studies Neoplasm Transplantation Multivariate Analysis Odds Ratio Oligonucleotide Array Sequence Analysis Blotting, Western Neoplasm Grading Chemotherapy, Adjuvant Transplantation, Heterologous Drug Administration Schedule Sensitivity and Specificity Immunoenzyme Techniques Risk Assessment Drug Screening Assays, Antitumor Polymerase Chain Reaction Confidence Intervals Registries Reproductive History Predictive Value of Tests Cohort Studies Proportional Hazards Models Transfection Incidence DNA Mutational Analysis Logistic Models Gynecologic Surgical Procedures SEER Program Reproducibility of Results Hysterectomy Flow Cytometry Questionnaires Gene Knockdown Techniques Ovariectomy Tumor Burden Infusions, Parenteral Mammary Neoplasms, Experimental Disease Models, Animal Genetic Testing Infusions, Intravenous ROC Curve Lymph Node Excision Models, Biological Molecular Targeted Therapy Enzyme-Linked Immunosorbent Assay Biopsy Clinical Trials as Topic

Psychiatry and Psychology1

Phenomena and Processes48

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA1 Genetic Predisposition to Disease Genes, BRCA2 Cell Proliferation Mutation Risk Odds Ratio Apoptosis Germ-Line Mutation DNA Methylation Sensitivity and Specificity Cell Growth Processes Genotype Genes, Tumor Suppressor Cell Survival Cell Movement Down-Regulation Dose-Response Relationship, Drug Up-Regulation Signal Transduction Time Factors Genes, p53 Cell Division Parity Transfection Polymorphism, Genetic Cell Cycle RNA Interference Loss of Heterozygosity Gene Expression Promoter Regions, Genetic Tumor Microenvironment Alleles Postmenopause Gene Amplification Base Sequence Heterozygote Phenotype Gene Silencing Menopause Genes, ras Diet Epigenesis, Genetic Phosphorylation Genes, Neoplasm Cell Adhesion

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Survival National Cancer Institute (U.S.)

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care32

Survival Analysis Survival Rate Disease-Free Survival Retrospective Studies Risk Factors Kaplan-Meier Estimate Treatment Outcome Follow-Up Studies Case-Control Studies Risk Prospective Studies Multivariate Analysis Odds Ratio Sensitivity and Specificity Risk Assessment Age Factors Confidence Intervals Registries Reproductive History Predictive Value of Tests Cohort Studies Proportional Hazards Models Parity Incidence Logistic Models SEER Program Reproducibility of Results Questionnaires National Cancer Institute (U.S.)Genetic Testing ROC Curve Clinical Trials as Topic

Geographicals3

United States Sweden Washington

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Adenocarcinoma Cystadenocarcinoma, Serous CA-125 Antigen Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Carcinoma, Endometrioid Carcinoma Tumor Markers, Biological Neoplasm Staging Cell Line, Tumor Gene Expression Regulation, Neoplastic Prognosis Paclitaxel Lung Neoplasms Early Detection of Cancer Neoplasm Invasiveness Drug Resistance, Neoplasm Survival Analysis Cisplatin Antineoplastic Agents Genes, BRCA1 Antineoplastic Combined Chemotherapy Protocols Pancreatic Neoplasms Stomach Neoplasms Immunohistochemistry Survival Rate Disease-Free Survival Peritoneal Neoplasms Carboplatin Mice, Nude Neoplasm Metastasis Neoplasm Recurrence, Local Cystadenocarcinoma, Mucinous Cystadenocarcinoma Endometrial Neoplasms Colonic Neoplasms Neoplasm Proteins Platinum Adenocarcinoma, Papillary Neoplasms, Cystic, Mucinous, and Serous Breast Neoplasms Ascites Prostatic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Disease Progression Esophageal Neoplasms Epididymal Secretory Proteins Platinum Compounds Second-Look Surgery Gene Expression Profiling Fallopian Tube Neoplasms Ovary Retrospective Studies Risk Factors Genetic Predisposition to Disease Genes, BRCA2 Tumor Cells, Cultured RNA, Messenger Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents, Phytogenic Kaplan-Meier Estimate Treatment Outcome DNA, Neoplasm Cell Proliferation Epithelial Cells Xenograft Model Antitumor Assays Follow-Up Studies Case-Control Studies Tissue Array Analysis BRCA2 Protein Combined Modality Therapy Antigens, Neoplasm Mutation Risk Prospective Studies Neoplasm Transplantation Multivariate Analysis Tumor Suppressor Protein p53 Odds Ratio Oligonucleotide Array Sequence Analysis BRCA1 Protein Carcinoma, Pancreatic Ductal Apoptosis Neoplasms Blotting, Western Germ-Line Mutation Neoplasm Grading Carcinoma, Squamous Cell Chemotherapy, Adjuvant RNA, Small Interfering Cell Transformation, Neoplastic Transplantation, Heterologous DNA Methylation Drug Administration Schedule Sensitivity and Specificity Cell Growth Processes Uterine Cervical Neoplasms Folate Receptor 1

No FAQ available that match "epithelial ovarian cancer cancers adenocarcinoma"